SCHEMBL6517686

SCHEMBL6517686

CN(N)c1ncnc2nc[nH]c12

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 2/20 0.73
PDPK1 O15530 2/20 0.73
CHEK1 O14757 1/20 0.73
AURKA O14965 1/20 0.73
CHEK2 O96017 1/20 0.73
HSP90AA1 P07900 1/20 0.73
HSP90AB1 P08238 1/20 0.73
PRKACA P17612 1/20 0.73
CCNE1 P24864 1/20 0.73
CDK2 P24941 1/20 0.73
MARK3 P27448 1/20 0.73
RPS6KA3 P51812 1/20 0.73
PRKCD Q05655 1/20 0.73
MARK2 Q7KZI7 1/20 0.73
HSD17B10 Q99714 3/20 0.59
EGFR P00533 1/20 0.59
CSF1R P07333 1/20 0.59
HTT P42858 8/20 0.58
MAP3K5 Q99683 1/20 0.58
NCOA1 Q15788 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30602928 1.00 LRRK2 (0.73) LRRK2PDPK1CHEK1AURKACHEK2
Dimethyladenine SCHEMBL152594 0.85 LRRK2 (1.00) LRRK2PDPK1CHEK1AURKACHEK2
Dimethyladenine SCHEMBL29349831 0.85 LRRK2 (1.00) LRRK2PDPK1CHEK1AURKACHEK2
SCHEMBL30544086 0.85 LRRK2 (0.67) LRRK2PDPK1CHEK1AURKACHEK2
Dimethyladenine SCHEMBL11157548 0.83 PDPK1 (0.96) LRRK2PDPK1CHEK1AURKACHEK2
SCHEMBL9096944 0.79 HSD17B10 (0.69) LRRK2PDPK1CHEK1AURKACHEK2
SCHEMBL29368416 0.77 PDPK1 (0.67) LRRK2PDPK1CHEK1AURKACHEK2
SCHEMBL9203283 0.76 HTT (0.76) LRRK2PDPK1CHEK1AURKACHEK2
SCHEMBL29529931 0.76 PDPK1 (0.66) LRRK2PDPK1CHEK1AURKACHEK2
SCHEMBL401116 0.76 PDPK1 (0.66) LRRK2PDPK1CHEK1AURKACHEK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050043268-A1 Inhibition of viruses MEDICAL RESEARCH COUNCIL (GB) 2005-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050043268-A1 Inhibition of viruses RNASE1, HNRNPA1, RNASEH1 LRRK2 4089/4885PDPK1 4629/4885CHEK1 4633/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.